{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-008377","form_type":"8-K","ticker":null,"cik":"0001779020","company_name":"Danimer Scientific, Inc.","filed_at":"2024-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.492674+00:00","generated_at":"2026-06-06T16:00:48.660320+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Danimer Scientific receives NYSE notice of non-compliance for stock price below $1.00","bullets":["NYSE notified Danimer on Jan 23, 2024 that average closing price was below $1.00 over 30 consecutive trading days ending Jan 22.","Company has six months to cure by having closing price at least $1.00 on last trading day of a month with 30-day average above $1.00.","Common stock (DNMR) will continue trading on NYSE during cure period, subject to other listing requirements.","Notice does not affect business operations, SEC reporting, or debt obligations."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-008377","json":"https://secwatch.observer/filing/0000950170-24-008377.json","markdown":"https://secwatch.observer/filing/0000950170-24-008377.md","text":"https://secwatch.observer/filing/0000950170-24-008377.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024008377/0000950170-24-008377-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024008377/dnmr-20240123.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T16:00:48.660320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"671caac4bdb7d72ae6081e4e6a3c3a9934a4f73f","claim":"Danimer Scientific, Inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).","evidence_excerpt":"January 23, 2024, Danimer Scientific, Inc. (the “Company”) was notified by NYSE Regulation (“NYSER”) that the Company is not in compliance with the New York Stock Exchange’s (“NYSE”) continued listing criteria under Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period as of January 22, 2024. The Company has notified the NYSE of its intent to cure the deficiency and return to compliance with the NYSE continued listing requirements. The Company will return to compliance if, d","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024008377/0000950170-24-008377-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nyse"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"802.01C"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}